Affinity Purification of Biologically Active and Inactive Forms of Recombinant Human Protein C Produced in Porcine Mammary Gland

Journal of Molecular Recognition

Volumn 9, Issue 5-6, 1996, Pages 407-414

  Van Cott, Kevin E ^a   Williams, Barry ^a   Velander, William H ^a   Gwazdauskas, Frank ^a   Lee, Tim ^b   Lubon, Henryk ^b   Drohan, William N ^b  

^a VIRGINIA POLYTECHNIC INSTITUTE AND STATE UNIVERSITY   (United States)

^b HOLLAND LABORATORY   (United States)

Author keywords

Affinity chromatography; Mammary gland; Porcine; Protein C; Transgenic

Indexed keywords

ANIMALIA; MURINAE; SUIDAE; SUS SCROFA;

CALCIUM CHLORIDE; PROTEIN C; RECOMBINANT PROTEIN;

AFFINITY CHROMATOGRAPHY; AMINO ACID SEQUENCE; ANIMAL; ARTICLE; BIOSYNTHESIS; CATTLE; ENZYME ACTIVATION; FEMALE; HUMAN; ISOLATION AND PURIFICATION; METABOLISM; METHODOLOGY; MOLECULAR GENETICS; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN CONFORMATION; SWINE; TRANSGENIC ANIMAL; UDDER; WESTERN BLOTTING;

AMINO ACID SEQUENCE; ANIMALS; ANIMALS, GENETICALLY MODIFIED; BLOTTING, WESTERN; CALCIUM CHLORIDE; CATTLE; CHROMATOGRAPHY, AFFINITY; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENZYME ACTIVATION; FEMALE; HUMANS; MAMMARY GLANDS, ANIMAL; MOLECULAR SEQUENCE DATA; PROTEIN C; PROTEIN CONFORMATION; RECOMBINANT PROTEINS; SWINE;

EID: 0030225322     PISSN: 09523499     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-1352(199634/12)9:5/6<407::AID-JMR277>3.0.CO;2-X     Document Type: Article

References (27)

1. Comp, P. C. (1990). The clinical potential of protein C and activated protein C. In Protein C and Related Anticoagulants, eds by D. F. Bruley and W. N. Drohan, pp. 181-186, Gulf Publishing Company, Houston, TX.
2. Drohan, W. N., Zhang, D.-W., Paleyanda, R. K., Chang, R., Wroble, M., Velander, W. and Lubon, H. (1994a). Inefficient processing of human protein C in the mouse mammary gland. Transgenic Res. 3, 355-364.
3. Drohan, W. N., Wilkins, T. D., Latimer, E., Zhou, D., Velander, W., Lee, T. K. and Lubon, H. (1994b). A scalable method for the purification of recombinant human protein C from the milk of transgenic swine. In Advances in Bioprocess Engineering, eds by E. Galindo and O. T. Ramirez, pp. 501-507. Kluwer Academic Publishers, Netherlands.
4. Esmon, C. T. (1985). The regulation of natural anticoagulant pathways. Science 235, 1348-1352.
5. Esmon, C. T. (1989). The roles of protein C and thrombomodulin in the regulation of blood coagulation. J. Biol. Chem. 264, 4743-4746.
6. Esmon, N. L., DeBault, L. E. and Esmon, C. T., 1983. Proteolytic formation and properties of γ-carboxyglutamic acid-domainless protein C, J. Biol. Chem. 258, 5548-5553.
7. Gelfi, C., Righetti, P. G. and Mannucci, P. M. (1985). Charge heterogeneity of human protein C revealed by isoelectric focusing in immobilized pH gradients. Electrophoresis 6, 373-376.
8. Grinnel, B. W., Walls, J. D., Gerlitz, B., Berg, D. T., McClure, D. B., Ehrlich, H., Bang, N. U. and Yan, S. B. (1990). Native and modified recombinant human protein C: function, secretion, and posttranslational modifications. Protein C and Related Anticoagulants, eds. D. F. Bruley and W. N. Drohan, 29-63. Gulf Publishing Company, Houston, TX.
9. Heeb, M. J., Schwarz, H. P., White, T., Lammle, B., Berrettini, M. and Griffin, J. H. (1988). Immunoblotting studies of the molecular forms of protein C in plasma. Thromb. Res. 52, 33-43.
10. Kang, K., Ryu, D., Drohan, W. N. and Orthner, C. L. (1992). Effect of matrices on affinity purification of protein C. Biotechnol. Bioeng. 39, 1086-1096.
11. Mann, K. G. and Bovill, E. G. (1990). Protein C deficiency and thrombotic risk. Protein C and related anticoagulants, eds. D. F. Bruley and W. N. Drohan, 119-123. Gulf Publishing Company, Houston, TX.
12. ®, a novel protein C activator. Thrombosis Research 43, 253-264.
13. McClure, D. B., Walls, J. D. and Grinnell, B. W. (1992). Posttranslational processing events in the secretion pathway of human protein C, a complex vitamin K-dependent antithrombotic factor. J. Biol. Chem. 267, 19710-19717.
14. Mesters, R. M., Houghten, R. A. and Griffin, J. H. (1991). Identification of a sequence of human activated protein C (residues 390-404) essential for its anticoagulant activity. J. Biol. Chem. 266, 24514-24519.
15. Mesters, R. M., Heeb, M. J. and Griffin, J. H. (1993a). A novel exosite in the light chain of human activated protein C essential for interaction with blood coagulation factor Va. Biochem. 32, 12656-12663.
16. Mesters, R. M., Heeb, M. J. and Griffin, J. H. (1993b). Interactions and inhibition of blood coagulation factor Va involving residues 311-325 of activated protein C. Protein Science 2, 1482-1489.
17. Miletich, J. P. and Broze, G. J. (1990). β protein C is not glycosylated at asparagine 329. J. Biol. Chem. 265, 11397-11404.
18. Morcol, T., Akers, R. M., Johnson, J. L., Williams, B. L., Gwazdauskas, F. C., Knight, J. W., Lubon, H. L., Paleyanda, R., Drohan, W. N. and Velander, W. H. (1994). The porcine mammary gland as a bioreactor for complex proteins. Ann. NY Acad. Sci. 721, 218-233.,
19. Subramanian, A., Van Cott, K. E., Millbrath, D. S. and Valender, W. H. (1994). Role of local antibody density effects on immunosorbent efficiency. J. Chromatogr. 672, 11-24.
20. 2-terminal region of protein C. J. Biol. Chem. 264, 18781-18788.
21. Paleyanda, R. K., Russell, C. G., Chang, R. R., Johnson, J., Velander, W., Drohan, W. N. and Lubon, H. (1995). γ-Carboxylation of human vitamin K-dependent proteins in the mouse mammary gland. Proceedings of the 1995 Miami Bio/Technology Winter Symposium Short Reports, 6, 108.
22. Velander, W. H., Morcol, T., Clark, D. B., Gee, G. and Drohan, W. N. (1990). Technological challenges for large-scale purification of protein C. Protein C and Related Anticoagulants, eds. D. F. Bruley and W. N. Drohan, 11-27. Gulf Publishing Company, Houston, TX.
23. Velander, W. H., Johnson, J. L., Page, R. L., Russell, C. G., Subramanian, A., Wilkins, T. D., Gwazdauskas, F. C., Pittius, C. and Drohan, W. N. (1992a). High-level expression of a heterologous protein in the milk of transgenic swine using the cDNA encoding human protein C. Proceedings of the National Academy of Sciences USA, 89, 12003-12007.
24. Velander, W. H., Page, R. L., Morcol, T., Russell, C. G., Canseco, R., Young, J. M., Drohan, W. N., Gwazdauskas, F. C., Wilkins, T. D. and Johnson, J. L. (1992b). Production of biologically active human protein C in the milk of transgenic mice. Annals of the New York Academy of Sciences 665, 391-403.
25. Wilkins, T. D. and Velander, W. (1992). Isolation of recombinant proteins from milk. J. Cell. Biochem. 49, 333-338.
26. Yan, S. C. B., Razzano, P., Chao, Y. B., Walls, J. D., Berg, D. T., McClure, D. B. and Grinnell, B. W. (1990). Characterization and novel purification of recombinant human protein C from three mammalian cell lines. Bio/Technology 8, 655-661.
27. 7D) of human activated protein C displays greatly reduced activity as an anticoagulant. Biochem. 29, 10828-10834.